Advertisement
XOM vs XRAY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is XOM is a Buy and XRAY is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
XOM’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).
- XOM’s FA Score: 1 green, 4 red.
- XRAY’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
XOM’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).
- XOM’s TA Score: 5 bullish, 5 bearish.
- XRAY’s TA Score: 3 bullish, 4 bearish.
Price Growth
XOM (@Integrated Oil) experienced а +0.83% price change this week, while XRAY (@Medical Specialties) price change was +6.82% for the same time period.
The average weekly price growth across all stocks in the @Integrated Oil industry was +2.28%. For the same industry, the average monthly price growth was +5.73%, and the average quarterly price growth was +8.56%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.68%. For the same industry, the average monthly price growth was +2.37%, and the average quarterly price growth was -0.79%.
Reported Earning Dates
XOM is expected to report earnings on Jul 25, 2025.
XRAY is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Integrated Oil (+2.28% weekly)Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.
@Medical Specialties (+1.68% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| XOM | XRAY | XOM / XRAY | |
| Capitalization | 461B | 6.69B | 6,889% |
| EBITDA | 74.3B | 249M | 29,839% |
| Gain YTD | 3.404 | -11.066 | -31% |
| P/E Ratio | 13.16 | 19.23 | 68% |
| Revenue | 335B | 3.97B | 8,449% |
| Total Cash | 31.5B | 334M | 9,431% |
| Total Debt | 41.6B | 2.3B | 1,809% |
XOM | XRAY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 8 | 100 | |
SMR RATING 1..100 | 57 | 96 | |
PRICE GROWTH RATING 1..100 | 56 | 61 | |
P/E GROWTH RATING 1..100 | 54 | 90 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XRAY's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for XOM (88) in the Integrated Oil industry. This means that XRAY’s stock grew significantly faster than XOM’s over the last 12 months.
XOM's Profit vs Risk Rating (8) in the Integrated Oil industry is significantly better than the same rating for XRAY (100) in the Medical Specialties industry. This means that XOM’s stock grew significantly faster than XRAY’s over the last 12 months.
XOM's SMR Rating (57) in the Integrated Oil industry is somewhat better than the same rating for XRAY (96) in the Medical Specialties industry. This means that XOM’s stock grew somewhat faster than XRAY’s over the last 12 months.
XOM's Price Growth Rating (56) in the Integrated Oil industry is in the same range as XRAY (61) in the Medical Specialties industry. This means that XOM’s stock grew similarly to XRAY’s over the last 12 months.
XOM's P/E Growth Rating (54) in the Integrated Oil industry is somewhat better than the same rating for XRAY (90) in the Medical Specialties industry. This means that XOM’s stock grew somewhat faster than XRAY’s over the last 12 months.
| XOM | XRAY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 48% | N/A |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 54% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 63% |
| Advances ODDS (%) | 7 days ago 63% | 8 days ago 58% |
| Declines ODDS (%) | 3 days ago 52% | 20 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 48% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 56% | 2 days ago 76% |
Advertisement
XOM and
Correlation & Price change
A.I.dvisor indicates that over the last year, XOM has been closely correlated with CVX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOM jumps, then CVX could also see price increases.
XRAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To XRAY | 1D Price Change % | ||
|---|---|---|---|---|
| XRAY | 100% | +4.16% | ||
| NVST - XRAY | 53% Loosely correlated | +2.46% | ||
| QDEL - XRAY | 50% Loosely correlated | +3.37% | ||
| ALGN - XRAY | 49% Loosely correlated | +2.61% | ||
| STE - XRAY | 47% Loosely correlated | N/A | ||
| KIDS - XRAY | 46% Loosely correlated | +1.77% | ||
More | ||||